Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 10 - 20 entities : Beyondspring, inc. save search
BeyondSpring Pharmaceuticals Announces New Patient-Derived Cancer Model Data for Plinabulin Monotherpy at the AACR-NCI-EORTC Virtual International Conference
Published: 2021-10-20 (Crawled : 20:00) - biospace.com/
BYSI | $1.8 -2.21% 80K
|
Health Technology
|
| O: 0.96%
H: 6.9%
C: -0.42%
cancer conference plinabulin
BeyondSpring Pharmaceuticals Announces New Patient-Derived Cancer Model Data for Plinabulin Monotherapy at the AACR-NCI-EORTC Virtual International Conference to Further Support the Positive Clinical Data Already Reported for the Treatment of Small Cell Lung Cancer
Published: 2021-10-20 (Crawled : 14:00) - beyondspringpharma.com
BYSI | $1.8 -2.21% 80K
|
Health Technology
|
| O: 0.96%
H: 6.9%
C: -0.42%
treatment lung cancer positive therapy cancer conference plinabulin
BeyondSpring Pharmaceuticals Announces New Patient-Derived Cancer Model Data for Plinabulin Monotherpy at the AACR-NCI-EORTC Virtual International Conference to Further Support the Positive Clinical Data Already Reported for the Treatment of Small Cell Lung Cancer
Published: 2021-10-20 (Crawled : 12:00) - beyondspringpharma.com
BYSI | $1.8 -2.21% 80K
|
Health Technology
|
| O: 0.96%
H: 6.9%
C: -0.42%
treatment lung cancer positive cancer conference plinabulin
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.